We promote research excellence in endocrinology and related fields by ensuring the needs and interests of researchers are met. We foster innovation by making knowledge easily found and shared. And we are committed to ensuring the expertise and perspective of science is represented at research funding agencies and reflected in policies and national issues that impact researchers.
Endocrine Society members this spring urged Congress to provide an increase of $3.2 billion for the National Institutes of Health (NIH) in fiscal year (FY) 2022, resulting in a total of $46.1 billion. Members discussed the importance of steady sustained increased funding for NIH, and the positive impact federal funding has on research discoveries in their own districts and states.
More patients than previously reported may experience hearing symptoms such as hearing loss or muffled hearing from a new treatment for thyroid eye disease TED), teprotumumab (Tepezza), according to a small study presented virtually at ENDO 2021. Teprotumumab, approved by the U.S. Food and Drug Administration in January 2020, is the first and only drug to be approved for TED.
Carol A. Lange, PhD, Editor-in-Chief of Endocrinology, and Stephen R. Hammes, MD, PhD, past Editor-in-Chief of Molecular Endocrinology share critical tips on how to get published.
Explore resources for pursuing endocrine-related research opportunities.
Join our endocrine community and become a member! Only members receive access to a variety of member benefits that will enhance your career. If your membership has lapsed, rejoin today so that you can continue to receive your membership benefits.
